Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Secondary and primary thrombocythemia]

L Judkiewicz1

  • 1Samodzielnej Pracowni Zaburzeń Krzepniecia Krwi Katedry Diagnostyki Laboratoryjnej A.M., Lodzi.

Acta Haematologica Polonica
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Low molecular weight heparins in prophylaxis and treatment of thromboembolic disorders].

Acta haematologica Polonica·1994
Same author

[Role of fibrinogen in cardiovascular diseases].

Acta haematologica Polonica·1994
Same author

Abnormal degradation of red cell membrane proteins in diabetes.

Cytobios·1993
Same author

[Familial occurrence of Glanzmann thrombasthenia].

Polski tygodnik lekarski (Warsaw, Poland : 1960)·1992
Same author

[Standard heparin and low molecular weight heparins].

Acta haematologica Polonica·1992
Same author

Consequences of the presence of elongated variant of the major transmembrane protein (Band 3 protein) in the human erythrocyte.

Clinica chimica acta; international journal of clinical chemistry·1991
Same journal

[Risk of transmission of blood-derived pathogens by transfusion in Poland].

Acta haematologica Polonica·2020
Same journal

[Emerging infectious diseases in the context of blood safety].

Acta haematologica Polonica·2020
Same journal

<i>Quo Vadis</i> medycyno regeneracyjna?: Quo Vadis Regenerative Medicine?

Acta haematologica Polonica·2013
Same journal

[RHnull syndrome--diagnostic and therapeutic problems].

Acta haematologica Polonica·1996
Same journal

[Unclassified chronic myeloproliferative Ph(-); i(17q); +8 syndrome with mixed myelo-megakaryoblastic crisis--case report].

Acta haematologica Polonica·1996
Same journal

Acute myelofibrosis in children: report on two cases.

Acta haematologica Polonica·1996
See all related articles

Reactive thrombocytosis involves high platelet counts due to other diseases, while essential thrombocythemia is a bone marrow disorder causing excess platelets and potential bleeding or clotting risks.

Area of Science:

  • Hematology
  • Oncology
  • Internal Medicine

Context:

  • Reactive thrombocytosis presents as an elevated platelet count secondary to various conditions including infections, inflammation, and neoplastic states.
  • Essential thrombocythemia is a myeloproliferative neoplasm characterized by excessive platelet production originating from megakaryocytes.

Purpose:

  • To differentiate reactive thrombocytosis from essential thrombocythemia.
  • To outline the distinct pathophysiological mechanisms and clinical features of each condition.

Summary:

  • Reactive thrombocytosis is a reactive increase in platelets linked to underlying diseases.
  • Essential thrombocythemia involves abnormal megakaryocyte proliferation, leading to high platelet counts, splenomegaly, and thrombotic or hemorrhagic complications.

Related Experiment Videos

Impact:

  • Clarifies diagnostic distinctions between reactive and essential thrombocytosis.
  • Provides foundational knowledge for understanding platelet count abnormalities and their clinical significance in hematologic disorders.